chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Face, neck and chest are numb; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 07Apr2021 at 15:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disorder (Thyroid disease) from an unspecified date. The patient had no known allergies. Concomitant medications included levothyroxine; liothyronine (NP THYROID); liothyronine (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D), riboflavin (VITAMIN B2), pantothenic acid (VITAMIN B5), pyridoxine hydrochloride (VITAMIN B6), multivitamin (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 13:00 the patient experienced face, neck and chest were numb. No swelling or hives. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event numbness was not recovered.   No follow-up attempts are needed. No further information is expected.
High anxiety.   Covid arm at day seven still continues.  Rash, itching, knot in arm, swelling and ache.  Ice, Tylenol and hydrocortisone cream.
This spontaneous report was received via a company representative from an unspecified healthcare worker and refers to a 65-year-old male patient. The patient's concomitant medications, pertinent medical history and drug reactions or allergies were not reported. On 17-NOV-2015, the patient was vaccinated with a dose of ZOSTAVAX vial, 0.65 ml (one dose), lot # L028282 (expiry date was not reported, route of administration unknown, reported as injection) to prevent Shingles, together with diluent (dose, frequency, lot #, expiry date and indication were not reported) and left for out of town. On an unknown date in 2015, the patient developed a "bad rash" and went to an unspecified emergency room (date not provided). There, he was diagnosed with chickenpox. Afterwards, in December 2015, the patient developed "numbing of the face". He went to an emergency room and was admitted to an unspecified hospital (dates of hospitalization were not provided). The patient was diagnosed with Bell's palsy (reported as belspalcy), caused by the chicken pox. Subsequently, in February 2016, the patient visited dermatologist due to the "lesions on his torso". The dermatologist first diagnosed the patient with eczema and attempted to burn off the lesions as a treatment. As the procedure was ineffective, the dermatologist changed their diagnosis to psoriasis and Koebner syndrome. Then, in March 2017, the patient experienced swelling behind the ear and behind the neck and went back to dermatologist, who diagnosed the patient with Shingles. The outcome of the events was reported as not recovered at the time of the report. The causality between ZOSTAVAX, diluent and the events was not reported. Upon internal review, the event of Bell's palsy was considered to be medically significant. Additional information has been requested.
Severe non stop headache radiating down back of neck and into shoulders, sinus infection, sore throat, hard to swallow, back and joint pain, loss of appetite, extreme fatigue.
Patient was under doctor's care for years. On October 4th, patient had an enzyme test and the numbers were low (45). He had the flu shot on October 16th. November 1st, he had stage 4 liver cancer. His enzymes were over 260. Patient died on 12/18/2001. Diagnosed at hospital with hepatomegally with liver mass, hypertention, GI bleeding/anemia. Also diagnosed with unstable angina. Pt sent to ER by MD for LUQ pain X 1 week per F/U 6/25/02 and afibrillation.
26y/o AD male J&J vaccine yesterday, today has Mild HA, but body feels heavy as if he is wearing his kevlar and full kit. denies NVD,
Pt presented to local ER with chest pain. Relieved with sublingual nitroglycine. Found to have high lipidemia and family hx significant for heart disease. Cardiologist confirmed ? right circumflex artery contributions to angina but still hospitalized.
Headache, Sedation, Myalgia, Arthralgia, Fever, Diarrhea & Nausea Vomiting Narrative:
Swollen lymph nodes left side of neck and back of neck. Soreness, nausea lymph nodes still swollen 10-5-10
One hour after injection on Sat., patient developed 4 x 6 in. area of redness, swelling, and tenderness at injection site. Later in day had neck stiffness, rash on back of neck, nausea, and diarrhea. Went to doctor on Monday who described reaction as "extreme end of normal." Symptoms tool 2 wks to resolve.
Shortly after getting the COVID vaccination, I have had issues with constant tinnitus. I never had these issues before. I have being trying to isolate the cause of the issue and the ENT specialists I have seen believe that the tinnitus may be a result of the vaccination. My hearing has recently been tested and is perfect, so the tinnitus is not tied to hearing loss. The tinnitus is a low level 10,000MHZ ringing and is constant.
Next day could not stand up without vomiting, fever 101, progressively worse as day went on to the point I could not lift my head off pillow. Could not eat, even sips of water or coke. Hard to breathe Day 2 fever 100 and slept most of day, still nauseous and dizzy with no appetite. Hard to breathe. Day 3 slept 12 hours and normal is 7 hours. Able to eat clear broth and drink lots of water.  Fever 99.9 but went down to just 99. Normal for me is 96 and sometimes 96. Hard to breathe. Day 4 Teeth look off color. Able to eat egg, but no sense of taste. Sleep almost back to normal, but no energy. Sudden movement or bending I get out of breath.
Woke up with a headache. Went to school and the headache got worse throughout the day. Was feeling so bad by the end of school she was unable to ride the bus because she was so nauseated. Displaying flu like symptoms.  Slept 3 hrs after school and still has headache. Dispensed Tylenol for headache and Mild fever.
This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 47-year-old female patient who received FLULAVAL (batch number XZ3SP, expiry date 30th June 2015). On 29th October 2014, the patient receivd FLULAVAL (intramuscular) .5 ml. In October 2014, less than a day after receiving FLULAVAL, the patient experienced injection site erythema, injection site warmth, injection site tenderness and injection site swelling. FLULAVAL was continued with no change. In 2014, the outcome of the injection site erythema, injection site warmth, injection site tenderness and injection site swelling were recovered/resolved. The reporter considered the injection site erythema, injection site warmth, injection site tenderness and injection site swelling to be probably related to FLULAVAL. Additional information was provided: A clinic reported that 5 different patients have experienced pretty severe injection reactions within 24 hours (not immediate) of receiving 0.5 ml of FLULAVAL. All the patients have had flu shots before with no previous reactions. Specifically, the injection site reaction consisted of redness, swelling, and tender and warm to the touch. All reactions were the size of a small apple/orange. The reactions were quite large and not a normal reaction that the clinic would expected. All the patients were later seen by the doctor with an office visit and the events have since resolved. This is one of the 5 cases reported by the same reporter for the same vaccine and with the same events.
Sore arm, muscle ache, fatigue. sore arm after a few hours, then muscle ache generally all over. Extreme fatigue. Sweating during the night. very tired and kind of achey the next dat till about 4:00pm. Overall symptons kicked in in about 4 hours and last 24 hours although vaccine site still sore 48 hours later.
Sore; Tired; Patch of redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore), FATIGUE (Tired) and VACCINATION SITE ERYTHEMA (Patch of redness) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (Sore), FATIGUE (Tired) and VACCINATION SITE ERYTHEMA (Patch of redness). On 12-Feb-2021, PAIN (Sore) and FATIGUE (Tired) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Patch of redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Around 1 am, I was sitting home watching tv and I started to smell blood coming from throat and I starting to feel like a blood chunk is coming out. And it happened. A medium sized blood chunk came out followed by couple small pieces of blood then I did drink lime mixed with water and stopped. But I still feel like there is something kind of blocking my throat a little bit.
Pt. reported having symptoms of unilateral facial weakening at 9:30 pm after receiving Gardasil and Menactra vaccinations at appointment earlier that day.  Patient went to the ER the next day.
Client experienced dizziness, fainting, vision disturbances, and fatigue beginning the morning after vaccination. Pt was advised to go to doctor immediately. Multiple attempts were made to follow -up. Unable to reach client or her mother.
June 21st, I had sore throat, I went to Urgent Care, and I had the PCR a test on 6/26.  Low fever, I had headaches, mostly fatigue, it lasted for 2 weeks, on July 1st.
ANAPHYLACTIC SHOCK; GUILLAIN BARRE; This spontaneous report received from a patient via social media via company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced anaphylactic shock, and guillain barre. The patient reported via social media that vaccine had caused anaphylactic shock and huge emergency room bill to the patient. Patient could not feel the feet but stated that arms, hands and fingers were mostly back to normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from guillain barre, and the outcome of anaphylactic shock was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211061612-covid-19 vaccine ad26.cov2.s-anaphylactic shock. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211061612-covid-19 vaccine ad26.cov2.s-Guillain Barre. This event(s) is labeled per RSI and is therefore considered potentially related.
Swollen lips after 4-6 hours  Discoloration of top  lip (purple in color) with redness on skin above.  Started peeling 2 days after, still with purple discoloration of top lip but improved.  vomiting for 2 days after - vomiting that evening. With headaches which also resolved after 2 days.
SEVERE REDNESS INITIALLY THAT TURNED INTO A FLUID FILLED MASS - 3-4 CM IN LENGHT, 2 CM IN WIDTH   - MY CLINICAL IMPRESSION WAS FAT NECROSIS.  AT TIME OF VISIT 3/4/2020 DID NOT HAVE PAIN OR REDNESS
My face started going numb on the right side, I believe it started on March 2, 2021. The right side of my face started to pull to the left side. I went to the emergency room, around 8PM on March 2, 2021. They did a bunch of tests, blood work was one and I don't remember the other test, it's been too long. The test results came back, and I was diagnosed with Bell's palsy. They admitted me for two days and monitored my symptoms. Since this happened, I've been doing speech and physical therapy.
Patient was given his second dose 21 days after his first dose instead of 28 days.  Patient has not experience any side effects.
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: 3 days after normal redness, swelling and pain subsided but 2 days later redness and swelling (no pain) returned and is also warm to the touch. No pain or discomfort. Not getting worse. She was advised to contact PCP monday to have evaluated and if pain or discomfort happens before then to visit an urgent care center. Patient will follow up after PCP visit.
diaphoretic, elevated HR, dizziness, "throat closing". Evaluated by EMS-Cleared
Generalized itchiness; This case was reported by a pharmacist via call center representative and described the occurrence of generalized pruritus in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix and the 1st dose of Influenza vaccine Quadrivalent 2019-2020 season. In September 2019, immediately after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced generalized pruritus. On an unknown date, the outcome of the generalized pruritus was recovered/resolved.   It was unknown if the reporter considered the generalized pruritus to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional case details were reported as follows: The age at vaccination was not reported. In September 2019, the patient received Shingrix and Flu shot, soon after the first dose of Shingrix the patient started experiencing generalized itchiness and as per the patient this symptom was manageable after first dose. The reporter consent to follow up. For tolerance after 2nd dose of Shingrix, refer case US2020AMR136308.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR136308:same reporter
Weakness and pain in arm. No fever, no redness or swelling at sight of injection but tender to the touch. Weakness and pain lasting 2 days +.
pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pain) and CHILLS (Chills). At the time of the report, PAIN (pain) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sunday (12/27/20) at 8pm began having chills/low grade fever which persisted through the night keeping me awake. Ranged from 99-101.7. Fever was gone by 9am the next day and no symptoms following other than mild sore throat. Uncertain if it was a virus. Tested negative for covid.
Headache, Arthralgia, right upper arm soreness, chills, dry sinuses Narrative:  Other Relevant History:
mixed in sterile solution instead of the proper diluent; mixed in sterile solution instead of the proper diluent; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA591A, expiry date 31st August 2022) for prophylaxis.   On 29th April 2022, the patient received Menveo. On 29th April 2022, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 03-MAY-2022 Reporter's Comment: The reporter was medical assistant. She stated that, she became aware of an administration of Menveo dose which was mixed in sterile solution instead of the proper diluent included in the packaging.  Transferred to medical information for further assistance and provided medical information agent with adverse event number. The reporter consented to follow up. Additional Supportive Information: She stated that, she became aware of an administration of Menveo dose which was mixed in sterile solution instead of the proper diluent included in the packaging, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
7/12/2021 Extreme swelling of the ankles and joint pain in hands, ankles and knees. 8/13/21 MD Live video appointment with doctor, advice was to go to ER. 8/14/21 attended ER, received Ultra Sound of legs for blood clots and EKGs. Doctor stated it could be Edema. 8/25/21 visited primary care doctor, he ordered a blood panel for all possibilities (arthritis, gout, sugar/salt in the blood, red/white blood cells, viruses, disease = all negative). Received anti-inflamatory for ankles Meloxicam 7.5mg 1xday, helps swelling slightly. 9/9/2021: Primary care for follow up of blood work, ankle swelling and joint pain, following an EKG during check up, fluttering of the heart was severe, I was admitted to Hospital for 2 days of monitoring my heart rate, blood pressure, and possibility of lime tick disease or zyga disease (results have not returned). Discharged from hospital with no answers, prescription for Metoprolol 25mg 1xday for fluttering. EKG showed no damage in heart, not sure what the fluttering is from, would happen even while sound asleep.
Purplish red spots on bottom of feet, lasted >day; headaches, fatigue, confusion, numbness in hands/ arms and feet.  All but spots continue today.  Nausea for 3 days, 3/29-3/31.  Diminished sense of smell and taste, still.
Slight headache; Sore arm; Tired; This is a spontaneous report from a contactable consumer (parent). A male patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on 02Jun2021 at 2nd dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 03Jun2021, patient woke up around 11am and had slight headache, which lasted all day, sore arm and tired. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
At about 8:15pm patient stated his throat itched on the inside. Gave him BENADRYL at that time. 30 min after taking BENADRYL symptoms started to improve.
Coughing, stomach pains, low oxygen levels, fatique, weight loss, loss of appetite.  This all started between 2 and 3 weeks after this shot.  Allergist prescribed Z-Pak, after that did not resolve the problem, he ordered another one.  On 3/5/23 I went to urgent care, my oxygen level was so low they sent me straight to the R.  They did EKG and Chest X-Ray after labs showed possible blood clots.  No blood clots.  I was given Prednisone.  On 3/30/23 my breathing got bad enough that I went to my regular doctor who prescribed me a higher dose of Advair and sent me to see my allergist the following day with a cough so bad I could barely drive to get there.  He prescribed me a nebulizer, which gave minimal results.  On April 26th I went bac to the Hospital and got more x-rays and a CT scan.  I was referred to a pulmonologist.  Next I had a bronchoscopy there on 5/12/23.  On 5/18/23 I had an ultrasound . On 5/23/23 I had more blood labs and a urine lab run.  I still don't know the results of these tests.  I am scheduled for 2 MRIs on June 22nd.  Somewhere in the middle of all that (5/14/23) I went to the ER for the terrible stomach pains that have been keeping me up each night.
Achiness; Fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achiness), PYREXIA (Fever) and FATIGUE (Tired) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised (take several medications), Cardiac disorder and Neurological disorder NOS.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Achiness), PYREXIA (Fever) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency; NAPROXEN for Adverse event, at an unspecified dose and frequency and TRIAMCINOLONE for Adverse event, at an unspecified dose and frequency. At the time of the report, MYALGIA (Achiness), PYREXIA (Fever) and FATIGUE (Tired) outcome was unknown.            Patient was having medication for neurological condition and cardiac condition. Patient was also having antibiotics and low dose steroids as concomitant medication for unknown indication.  Treatment medication included Ice cool compresses   This case was linked to MOD-2021-373406, MOD-2021-373419 (Patient Link).
One week and one day after receiving the vaccine, I broke out in head-to-toe hives.  Took Zyrtec. The following day I was mostly stable.  Friday May 7th had extreme swelling and pain on bottom of feet and could not walk.  Saturday May 8th broke out in severe hives and went to Urgent Care.  Given Prendisone and told to keep taking Zyrtec and Benedryl.  Was taking Benedryl every 3 hours to stop the reaction. It was out of control. Sunday May 9th broke out in an even more severe reaction from head to toe and went to the ER. Nothing more was done.  Over a week of taking Benedryl and Zyrtec.   After receiving the second COVID shot the same reaction (not as severe) happened again one week later. Have been taking Zyrtec or Allegra as needed since the first and second doses.  At this point the hives have lessened and are triggered by cold and sometimes triggered by extreme exertion and sweating. Not sure of other triggers.
A physician reported that a 57 year-old male (race and ethnicity not provided) received "2 vials" of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization as a booster. No relevant medical history was reported. No relevant concomitant medications were reported. On an unspecified date, the patient received the two doses of HEPLISAV-B (Lot #, expiration date and NDC # 43528-002-01) intramuscularly. The patient was given "two vials" of HEPLISAV-B as a booster because the person giving the injection saw that the Engerix dose was 40 mcg. Following injection, the person double checked the information and called the physician. No adverse reactions were reported. No additional information was reported.    Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.